# A Study to Access of Daratumumab Combined With VRD in the Treatment of Patients With Standard-risk Newly Diagnosed MM

> **NCT05088330** · NA · UNKNOWN · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 76 (estimated)

## Conditions studied

- Newly Diagnosed Multiple Myeloma

## Interventions

- **DRUG:** Daratumumab

## Key facts

- **NCT ID:** NCT05088330
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2023-05-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2021-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05088330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05088330, "A Study to Access of Daratumumab Combined With VRD in the Treatment of Patients With Standard-risk Newly Diagnosed MM". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05088330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*